Literature DB >> 19460098

Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.

S Hower1, K Wolf, K A Fields.   

Abstract

Chlamydia trachomatis is an obligate intracellular parasite, occupies a membrane-bound vacuole throughout development and is capable of manipulating the eukaryotic host by translocating effector molecules via a type III secretion system (T3SS). The infectious chlamydial elementary body (EB) is metabolically inactive yet possesses a functional T3S apparatus capable of translocating effector proteins into the host cell to facilitate invasion and other early cycle events. We present evidence here that the C. trachomatis protein CT694 represents an early cycle-associated effector protein. CT694 is secreted by the Yersinia T3SS and immunodetection studies of infected HeLa cultures indicate that CT694-specific signal accumulates directly adjacent to, but not completely overlapping with EBs during invasion. Yeast two-hybrid analyses revealed an interaction of CT694 with the repeat region and C-terminus of human AHNAK. Immunolocalization studies of CT694 ectopically expressed in HeLa cells were consistent with an interaction with endogenous AHNAK. Additionally, expression of CT694 in HeLa cells resulted in alterations in the detection of stress fibres that correlated with the ability of CT694 to interact with AHNAK. These data indicate that CT694 is a novel T3S-dependent substrate unique to C. trachomatis, and that its interaction with host proteins such as AHNAK may be important for aspects of invasion or development particular to this species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460098      PMCID: PMC2997736          DOI: 10.1111/j.1365-2958.2009.06732.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  46 in total

1.  Role of penicillin-binding protein PBP 2B in assembly and functioning of the division machinery of Bacillus subtilis.

Authors:  R A Daniel; E J Harry; J Errington
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

Review 2.  The PASTA domain: a beta-lactam-binding domain.

Authors:  Corin Yeats; Robert D Finn; Alex Bateman
Journal:  Trends Biochem Sci       Date:  2002-09       Impact factor: 13.807

3.  Characterization of an isogenic set of methicillin-resistant and susceptible mutants of Staphylococcus aureus.

Authors:  B Berger-Bächi; A Strässle; F H Kayser
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

4.  Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus.

Authors:  B J Hartman; A Tomasz
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

5.  An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci.

Authors:  M G Pinho; H de Lencastre; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

6.  Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus.

Authors:  M G Pinho; S R Filipe; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

7.  Geometry of cell division in Staphylococcus aureus.

Authors:  H Tzagoloff; R Novick
Journal:  J Bacteriol       Date:  1977-01       Impact factor: 3.490

Review 8.  A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway.

Authors:  Sarah Dubrac; Paola Bisicchia; Kevin M Devine; Tarek Msadek
Journal:  Mol Microbiol       Date:  2008-10-23       Impact factor: 3.501

9.  Penicillin-binding proteins in bacteria.

Authors:  N H Georgopapadakou; F Y Liu
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

10.  Evidence for involvement of penicillin-binding protein 3 in murein synthesis during septation but not during cell elongation.

Authors:  G A Botta; J T Park
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

View more
  61 in total

1.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

2.  Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins.

Authors:  Holly D Bullock; Suzanne Hower; Kenneth A Fields
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

3.  Disulfide bonding within components of the Chlamydia type III secretion apparatus correlates with development.

Authors:  H J Betts-Hampikian; K A Fields
Journal:  J Bacteriol       Date:  2011-10-14       Impact factor: 3.490

Review 4.  New frontiers in type III secretion biology: the Chlamydia perspective.

Authors:  K E Mueller; G V Plano; K A Fields
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

5.  Chlamydia trachomatis Slc1 is a type III secretion chaperone that enhances the translocation of its invasion effector substrate TARP.

Authors:  Amanda J Brinkworth; Denise S Malcolm; António T Pedrosa; Katarzyna Roguska; Sevanna Shahbazian; James E Graham; Richard D Hayward; Rey A Carabeo
Journal:  Mol Microbiol       Date:  2011-09-02       Impact factor: 3.501

6.  Hypothetical protein CT398 (CdsZ) interacts with σ(54) (RpoN)-holoenzyme and the type III secretion export apparatus in Chlamydia trachomatis.

Authors:  Michael L Barta; Kevin P Battaile; Scott Lovell; P Scott Hefty
Journal:  Protein Sci       Date:  2015-08-06       Impact factor: 6.725

7.  Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1.

Authors:  Siqi Gong; Lei Lei; Xiaotong Chang; Robert Belland; Guangming Zhong
Journal:  Microbiology (Reading)       Date:  2011-01-13       Impact factor: 2.777

8.  Chlamydia trachomatis ChxR is a transcriptional regulator of virulence factors that function in in vivo host-pathogen interactions.

Authors:  Chunfu Yang; Laszlo Kari; Gail L Sturdevant; Lihua Song; Michael John Patton; Claire E Couch; Jillian M Ilgenfritz; Timothy R Southern; William M Whitmire; Michael Briones; Christine Bonner; Chris Grant; Pinzhao Hu; Grant McClarty; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2017-04-01       Impact factor: 3.166

9.  Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells.

Authors:  Jin Wang; Kyla M Frohlich; Lyndsey Buckner; Alison J Quayle; Miao Luo; Xiaogeng Feng; Wandy Beatty; Ziyu Hua; Xiancai Rao; Maria E Lewis; Kelly Sorrells; Kerri Santiago; Guangming Zhong; Li Shen
Journal:  Microbiology (Reading)       Date:  2011-07-07       Impact factor: 2.777

Review 10.  A working model for the type III secretion mechanism in Chlamydia.

Authors:  Joshua C Ferrell; Kenneth A Fields
Journal:  Microbes Infect       Date:  2015-10-26       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.